Replication-selective microbiological agents: fighting cancer with targeted germ warfare

[1] ASADA T, 1974, CANCER, V34, P1907, DOI 10.1002/1097-0142(197412)34:6<1907::AID-CNCR2820340609>3.0.CO

[2] 2-4

[3] Coley W.B., 1893, AM J MED SCI, V105, P487, DOI DOI 10.1097/00000441-189305000-00001

[4] Coley WB, 1911, SURG GYNECOL OBSTET, V13, P174

[5] Dock G, 1904, AM J MED SCI, V127, P563

[6] ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents [J]. NATURE MEDICINE, 1997, 3 (06) : 639 - 645

[7] KIRN D, 1998, P AN M AM SOC CLIN, V17, pA391

[8] KIRN DH, 1999, P AN M AM SOC CLIN, V18, P1505

[9] Lattime EC, 1996, SEMIN ONCOL, V23, P88

[10] ATTENUATED MULTI-MUTATED HERPES-SIMPLEX VIRUS-1 FOR THE TREATMENT OF MALIGNANT GLIOMAS [J]. NATURE MEDICINE, 1995, 1 (09) : 938 - 943

[1] ASADA T, 1974, CANCER, V34, P1907, DOI 10.1002/1097-0142(197412)34:6<1907::AID-CNCR2820340609>3.0.CO

[2] 2-4

[3] Coley W.B., 1893, AM J MED SCI, V105, P487, DOI DOI 10.1097/00000441-189305000-00001

[4] Coley WB, 1911, SURG GYNECOL OBSTET, V13, P174

[5] Dock G, 1904, AM J MED SCI, V127, P563

[6] ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents [J]. NATURE MEDICINE, 1997, 3 (06) : 639 - 645

[7] KIRN D, 1998, P AN M AM SOC CLIN, V17, pA391

[8] KIRN DH, 1999, P AN M AM SOC CLIN, V18, P1505

[9] Lattime EC, 1996, SEMIN ONCOL, V23, P88

[10] ATTENUATED MULTI-MUTATED HERPES-SIMPLEX VIRUS-1 FOR THE TREATMENT OF MALIGNANT GLIOMAS [J]. NATURE MEDICINE, 1995, 1 (09) : 938 - 943